Search results
Found 16149 matches for
The University of Oxford and Sound Pharmaceuticals completed this new Phase 2a study testing SPI-1005, an investigational drug that contains ebselen, as a new treatment for bipolar disorder.
Psychiatry Annual Report 2023
Psychiatry annual report 2-23 - read a fully accessible version of the text below
Psychosocial assessment following self-harm
Psychosocial assessment following self-harm: a clinician's guide
PSYCHOSOCIAL assessment following self-harm Clinician's guide.pdf (916 KB)